Donor type and post-transplant outcomes in anti-thymocyte globulin based allogeneic transplantation for myelodysplastic syndromes.

Ann Hematol · 2026 · PMC13095986 · PMID 42010126

Europe PMC DOI

hedged sentences

0.0660

closest p · 1.3× alpha

0.2750

boldest claim

The sentences

showed a trendp = 0.066so close (0.05 < p ≤ 0.1)

4 ), the MSD group showed a trend toward inferior OS ( p = 0.066) and RFS ( p = 0.052) compared with the alternative donor group, accompanied by a higher relapse rate ( p = 0.003).

also in 53,322 other papers

a marginal trendp = 0.081so close (0.05 < p ≤ 0.1)

Both UD and HID showed lower hazard ratios for RFS compared with MSD (HR 0.721 95% CI 0.467–1.114, and HR 0.695, 95% CI 0.462–1.046, respectively), though only HID exhibited a marginal trend toward improved outcomes ( p = 0.081).

also in 626 other papers

did not reach statistical significancep = 0.275not close (p > 0.1)

Although UD and HID showed lower hazard ratios for mortality compared to MSD, these did not reach statistical significance ( p = 0.275 and p = 0.209, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.